title: High-dose vitamin C therapy for inclusion body myositis.
abstract: OBJECTIVE
  The efficiency of high-dose vitamin C therapy for inclusion body myositis (IBM) was assessed.
  
  
  METHODS
  The subjects were five patients with IBM confirmed pathologically. After the intravenous administration of 40 mg/kg vitamin C five times/week for four weeks, muscle weakness was found to improve in three cases. The average muscle score improved from 8.1 to 8.8, from 7.0 to 8.1 and from 6.2 to 6.8. Magnetic resonance imaging (MRI) demonstrated a reduction in the size of T2 high lesions and gadolinium enhancement in the thigh muscles in one case. Based on our findings, high-dose vitamin C therapy is considered to be effective in some cases of IBM.
authors: Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan. yamada@neuro.med.kyushu-u.ac.jp
authors: T
authors: T
authors: Yamada
authors: M
authors: M
authors: Minohara
authors: Y
authors: Y
authors: Imaiso
authors: N
authors: N
authors: Sakae
authors: H
authors: H
authors: Hara
authors: K
authors: K
authors: Tanaka
authors: T
authors: T
authors: Yamamoto
authors: T
authors: T
authors: Taniwaki
authors: H
authors: H
authors: Furuya
authors: J
authors: J
authors: Kira
mesh_terms: D000368:Aged; D001205:Ascorbic Acid / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D018979:Myositis, Inclusion Body / Q000188:drug therapy*
chemical_list: D001205:Ascorbic Acid